STUDI PENGGUNAAN ANTIBIOTIKA GOLONGAN PENISILIN PADA PASIEN PNEUMONIA PEDIATRI RAWAT INAP (Penelitian di Rumah Sakit Umum Daerah Dr. Saiful Anwar Malang)
| Main Author: | Nugroho, Dimas Purwo |
|---|---|
| Format: | Thesis NonPeerReviewed |
| Terbitan: |
, 2013
|
| Subjects: | |
| Online Access: |
http://eprints.umm.ac.id/30571/ |
Daftar Isi:
- Pneumonia is a lungs inflammation which caused by microorganism (bacteria, fungus, virus, and paracyte). The inflammation process will caused lungs tissue or alveoli (air pouch) filled by liquid or pus. Pneumonia divided into two categories, nosocomial pneumonia and community pneumonia. Streptococcus group B and Listeriae monocytogenes are the most common cause in neonates. Besides, Streptococcus pneumoniae is a major cause in bacterial pneumonia. At pneumonia pediatric patients, beta lactam group (Penicillin, Cephalosporin, Carbapenem, Monobactam) is a kind of antibiotics were widely known and usually used for pneumonic therapy caused by bacteria such as Streptococcus pneumoniae, Haemophillus influenza, dan Staphylococcus aureus. To know the profile used in antibiotics penicillin group at hospitalized pneumonia pediatric patients at Hospital of Dr. Saiful Anwar Malang, for later do some analysis of the data, accuracy of dose and frequency, route, duration and timing of administration which related by it clinical data. The research was a descriptive form of retrospective studies, yaitu observational research which followed the history of disease backwards at pneumonia pediatric patients from 1 January to 31 December 2011. From 44 patients obtained: single antibiotics 20,68%, combinations of two antibiotics 70,68%, and a combinations of three antibiotics 8,62%. The most of use in single antibiotics is ampicillin 35,71%. For combinations of two antibiotics, group of penicillin is a most used which ampicillin + chloramphenicol have 31 patients 54,38%. And in combinations of three antibiotics, the most used group of penicillin are (ampicillin sulbactam, gentamycin, and meropenem), (amoxyclav, gentamycin, and meropenem), (ampicillin sulbactam, gentamycin, and cloxacillin), (ampicillin sulbactam, gentamycin, and meropenem {2}), 1 patient each (16,67%)